GlaxoSmithKline PLC Director/PDMR Shareholding (2326Q)
24 Febrero 2021 - 7:59AM
UK Regulatory
TIDMGSK
RNS Number : 2326Q
GlaxoSmithKline PLC
24 February 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Dr H Barron
==== ======================================== =================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== =================================================
b) Nature of the Acquisition of notional ADSs within Dr
transaction Barron's GSK Executive Supplemental Savings
Plan account
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
$34.4400 1,223.249
===================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =====================================================
e) Date of the transaction 2021-02-22
==== ======================================== =================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ======================================================================================
a) Name Dr H Barron
==== ======================================== ============================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================== ============================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ======================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ============================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ======================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== ============================================
b) Nature of the Acquisition of ADSs within Dr Barron's
transaction GSK 401(k) Plan account
==== ======================================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ================== =====================
$34.4400 219
================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ================================================
e) Date of the transaction 2021-02-22
==== ======================================== ============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHXZLFLFLLEBBD
(END) Dow Jones Newswires
February 24, 2021 08:59 ET (13:59 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De May 2023 a May 2024